What pandemic? Industry-sponsored clinical trial activity has returned to pre-pandemic trends now that the turmoil of COVID-19 has abated. Find out more: https://ow.ly/K8i150Sl53u. Citeline’s annual analysis of completed clinical trials shows that the industry is back where it was at the end of the last decade. The focus on infectious diseases and vaccines has tapered off, and disruptions to other trials have come to an end. #ClinicalTrials #PharmaResearch #HealthcareNews #DrugDevelopment #ClinicalResearch
Citeline Commercial’s Post
More Relevant Posts
-
Discover the winning formula behind blockbuster drugs! Out of the 487 drugs approved in the US between 2014 and 2023, an impressive 193 are projected to exceed $1 billion in peak-year sales. Download your free copy: https://ow.ly/N3vo50SsXKK.
-
-
In the next five years, people will have their own artificial intelligence “agent” using their own personalized data to help them make health decisions. This is what Andrew Trister, chief medical and scientific officer at Verily (formerly Google Life Sciences) predicts. In this two-part series, Trister discusses his vision for precision health, an approach that brings together data from a wide range of sources, including wearables, lab tests, diagnostics, and social determinants, such as where someone lives, to personalize how they manage their health. Learn about his vision for the future and current obstacles: https://ow.ly/RUGs50Rh5YS Don't miss part-one: https://ow.ly/rvwz50Rh5YT #ArtificialIntelligence #HealthTech #HealthcareInnovation #FutureOfHealth #HealthData
In Five Years, People Will Navigate Their Health Care With An AI Advisor – Verily’s Andrew Trister
medtech.citeline.com
-
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma Pharmaceuticals, Lupin and Viatris announcing new hires. Read the report now: https://ow.ly/Bhi650SsVKB. This report offers details of the latest high-level appointments in the generics industry, with Hikma's generics segment coming under new leadership and Viatris appointing a new CCO. Meanwhile, API giant EuroAPI is streamlining its leadership team amid recent difficulties. #PharmaNews #GenericsIndustry #HealthcareIndustry #HikmaPharmaceuticals #Lupin #Viatris
-
-
AI is increasingly making its way into health care. At the recent Precision Med Tri-Con conference, health care leaders and AI enthusiasts Eric Topol and Doug Flora discussed how AI integration will change the way doctors practice medicine and patients receive care. Flora described use cases at St. Elizabeth Healthcare in Kentucky, including AI to help radiologists read scans and improve productivity and accuracy in mammography. Topol, a renowned cardiologist and bestseller author, talked about how AI should be combined with a wide range of personalized data. Read it now: https://ow.ly/bG1b50RGmHQ. #AIinHealthcare #PrecisionMedicine #ArtificialIntelligence #HealthcareInnovation #RadiologyAI #MedicalAI #HealthcareConference
‘Biggest Transformation In The History Of Medicine’: Oncologist And Cardiologist Talk AI-Enabled Health Care
-
📢 Last call! This is your last chance to enter The Citeline Japan Awards 2024! ✨ This is your time to shine among the best in Japanese pharma and biotech. Join us in Tokyo on October 22nd for an unforgettable evening of innovation and inspiration. Don’t wait—submit your entries today using the link below! 🌟 https://lnkd.in/gqNyeeBd #CitelineJapanAwards
-
-
A paper published by the Association for Accessible Medicines's (AAM) Biosimilars Council has called for a streamlining of the FDA’s approval process for biosimilars. Read more: https://ow.ly/FiCP50SrItS.
-
-
Not long ago, the gap between China and the US in biotech was narrowing, but geopolitical tensions including growing suspicion between China and US authorities are having an impact on companies in the sector. This article analyzes the recent slide in share values and restrictions plans of China-based biotech companies, including contract research, development, and manufacturing companies. Read now: https://ow.ly/k92g50QKYBk #ChinaUSRelations #BiotechIndustry #HealthcareAnalysis
Hidden Dragon? Investors Return To New China Biotech Reality
scrip.citeline.com
-
🏆 WuXi AppTec Biotech Company of the Year 🏆 The winner of this award at the 2023 Scrip Awards was MoonLake Immunotherapeutics (NASDAQ: MLTX). Entries are open for the 2024 Scrip Awards: https://ow.ly/UJK950Rzqjw. #BiotechIndustry #ScripAwards #BiotechInnovation #BiotechLeadership #InnovativeTherapeutics #BiotechAchievement
-
Want an inside view of the changing face of oncology development? Get your free insights in partnership with IQVIA now: https://ow.ly/ftak50SpqQv. Don’t miss insights into how this new paradigm impacts sponsors and how building dose finding and optimization into early clinical development allows for more sophisticated analysis of dose and schedule. #OncologyDevelopment #IQVIA #OncologyResearch #ClinicalResearch
-
